Volume Buzz: Amarin, CVR Refining, Usana Health Sciences

Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Amarin (AMRN +1%) gains after saying it's submitted a Supplemental New Drug Application with the FDA seeking approval for the marketing and sale of Vascepa capsules for use as an adjunct to diet in the treatment of adult patients with high triglycerides with mixed dyslipidemia. The drug is already approved to treat hypertriglyceridemia, and if cleared for the new indication, it will be the only approved prescription omega 3 therapy for cardiovascular health management in this patient population.

Is AMRN a Still a Buy after the Solid momentum? Let’s Find out Here

Coverage of CVR Refining (CVRR -4.1%) is initiated with mostly middling recommendations by at least four sell-side firms: an Equal Weight at Barclays, a Neutral at Credit Suisse, a Neutral at Citigroup, and a Buy at UBS. CVRR's profitability is leveraged to operations of just two assets: its 115M bbl/day Coffeyville, Kan., and 70M bbl/day Wynnewood, Okla., refineries.

Is CVRR a Strong Buying Opportunity After The Recent Slump? Find out Here

Usana Health Sciences (USNA -1.6%) slips today, despite its announcement that its China subsidiary BabyCare Ltd. has been given the official government stamp of approval from the People's Republic of China to expand direct selling activities in 3 additional provinces; Jiangsu, Shanxi and Tianjin.

Should USNA Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.